The Journal of Clinical Psychiatry

Page 685

More JCP Articles

Original Research

Metrifonate: Update on a New Antidementia Agent

November 30, 1999

Jeffrey L. Cummings, John M. Ringman

Editorial

Millennial Musings

November 30, 1999

Alan J. Gelenberg

Original Research

Olanzapine Increases Weight and Serum Triglyceride Levels

November 30, 1999

David N. Osser, Dean M. Najarian, Robert L. Dufresne

Letter to the Editor

Once-Daily Venlafaxine XR Compared With Fluoxetine in Outpatients With Depression and Anxiety

November 30, 1999

Rajinder Judge, Brian E. Wagner

Letter to the Editor

Paroxetine for Primary Insomnia: Possible Placebo Effect?

November 30, 1999

Mahmoud N. Musa

Letter to the Editor

Recommended Haloperidol and Risperidone Doses in First-Episode Psychosis

November 30, 1999

Patrick D. McGorry

Original Research

Relationship Between Borderline Personality Disorder and Axis I Diagnosis in Severity of Depression and Anxiety

November 30, 1999

David L. Dunner, Peter P. Roy-Byrne, Deborah S. Cowley, et al

Letter to the Editor

Reply to Letter to the Editor “Once-Daily Venlafaxine XR Compared With Fluoxetine in Outpatients With Depression and Anxiety”

November 30, 1999

Peter H. Silverstone, Arun Ravindran

Letter to the Editor

Reply to Letter to the Editor “Recommended Haloperidol and Risperidone Doses in First-Episode Psychosis”

November 30, 1999

John R. DeQuardo

Letter to the Editor

Reply to Letter to the Editor “Safety of Sildenafil for Antidepressant-Related Sexual Dysfunction”

November 30, 1999

H. George Nurnberg, Paula L. Hensley, John Lauriello, et al

Letter to the Editor

Safety of Sildenafil for Antidepressant-Related Sexual Dysfunction

November 30, 1999

Ronald Pies

Brainstorms

Molecular Neurobiology for Practicing Psychiatrists, Part 3: How Second Messengers “Turn On” Genes by Activating Protein Kinases and Transcription Factors

November 30, 1999

Stephen M. Stahl

« 1 … 683 684 685 686 687 … 774 »

Metrifonate: Update on a New Antidementia Agent

Millennial Musings

Olanzapine Increases Weight and Serum Triglyceride Levels

Once-Daily Venlafaxine XR Compared With Fluoxetine in Outpatients With Depression and Anxiety

Paroxetine for Primary Insomnia: Possible Placebo Effect?

Recommended Haloperidol and Risperidone Doses in First-Episode Psychosis

Relationship Between Borderline Personality Disorder and Axis I Diagnosis in Severity of Depression and Anxiety

Reply to Letter to the Editor “Once-Daily Venlafaxine XR Compared With Fluoxetine in Outpatients With Depression and Anxiety”

Reply to Letter to the Editor “Recommended Haloperidol and Risperidone Doses in First-Episode Psychosis”

Reply to Letter to the Editor “Safety of Sildenafil for Antidepressant-Related Sexual Dysfunction”

Safety of Sildenafil for Antidepressant-Related Sexual Dysfunction

Molecular Neurobiology for Practicing Psychiatrists, Part 3: How Second Messengers “Turn On” Genes by Activating Protein Kinases and Transcription Factors

ELSEWHERE:

FOLLOW US:

More JCP Articles

Metrifonate: Update on a New Antidementia Agent

Millennial Musings

Olanzapine Increases Weight and Serum Triglyceride Levels

Once-Daily Venlafaxine XR Compared With Fluoxetine in Outpatients With Depression and Anxiety

Paroxetine for Primary Insomnia: Possible Placebo Effect?

Recommended Haloperidol and Risperidone Doses in First-Episode Psychosis

Relationship Between Borderline Personality Disorder and Axis I Diagnosis in Severity of Depression and Anxiety

Reply to Letter to the Editor “Once-Daily Venlafaxine XR Compared With Fluoxetine in Outpatients With Depression and Anxiety”

Reply to Letter to the Editor “Recommended Haloperidol and Risperidone Doses in First-Episode Psychosis”

Reply to Letter to the Editor “Safety of Sildenafil for Antidepressant-Related Sexual Dysfunction”

Safety of Sildenafil for Antidepressant-Related Sexual Dysfunction

Molecular Neurobiology for Practicing Psychiatrists, Part 3: How Second Messengers “Turn On” Genes by Activating Protein Kinases and Transcription Factors

Insightful. Evidence-based. Human-centered.

Subscribe to readmore articles

Subscribe to read
more articles